News
05-11-2010, 01:30 AM
A study by researchers from the Georgetown Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC) identifies a potential new combination therapy to "rescue" treatment sensitivity to fulvestrant in estrogen receptor positive breast cancers.
More... (http://www.news-medical.net/news/20100511/New-combination-therapy-may-help-treat-anti-estrogen-resistant-ER2b-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20100511/New-combination-therapy-may-help-treat-anti-estrogen-resistant-ER2b-breast-cancer.aspx)